These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2950862)

  • 41. Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines.
    Sano H; Kumagai S; Namiuchi S; Uchiyama T; Yodoi J; Maeda M; Takatsuki K; Suginoshita T; Imura H
    Clin Exp Immunol; 1986 Jan; 63(1):8-16. PubMed ID: 3006953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic lupus erythematosus with deficiency of the T4 epitope on T4 helper/inducer cells.
    N Engl J Med; 1985 Dec; 313(24):1544-5. PubMed ID: 2415819
    [No Abstract]   [Full Text] [Related]  

  • 43. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells.
    Huang YP; Miescher PA; Zubler RH
    J Immunol; 1986 Dec; 137(11):3515-20. PubMed ID: 2946762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus.
    Frazer IH; Mackay IR
    Clin Exp Immunol; 1982 Oct; 50(1):107-14. PubMed ID: 6216997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors.
    Sibbitt WL; Froelich CJ; Bankhurst AD
    Clin Exp Immunol; 1983 Aug; 53(2):363-70. PubMed ID: 6883808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T cell subsets in patients with systemic lupus erythematosus.
    Kucharz EJ; Sierakowski SJ
    Med Interne; 1988; 26(3):227-33. PubMed ID: 2973120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus.
    Mahowald ML; Dalmasso AP
    Ann Rheum Dis; 1982 Dec; 41(6):593-8. PubMed ID: 7149796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosus.
    Gray JD; Lash A; Bakke AC; Kitridou RC; Horwitz DA
    Clin Exp Immunol; 1987 Mar; 67(3):556-64. PubMed ID: 2955974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The induction of human antinuclear antibodies by D-penicillamine: activation of inducer helper T cells in the absence of irradiation sensitive suppressor T cells.
    Mach PS; Brouilhet H; Amor B
    Clin Exp Immunol; 1986 Feb; 63(2):408-13. PubMed ID: 2938856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defective expression of OKT4 antigen on the cell surface of helper T lymphocytes in a patient with systemic lupus erythematosus.
    Ichikawa Y; Lavastida MT; Gonzales EB; Daniels JC
    Clin Exp Rheumatol; 1983; 1(4):299-305. PubMed ID: 6241856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antilymphocyte antibodies in systemic lupus erythematosus. Effect on lymphocyte surface characteristics.
    Messner RP; Kennedy MS; Jelinek JG
    Arthritis Rheum; 1975; 18(3):201-6. PubMed ID: 1095019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products.
    Litvin DA; Cohen PL; Winfield JB
    J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of antilymphocyte antibodies in patients with systemic lupus erythematosus by indirect immunofluorescence on acetone-fixed lymphocytes.
    Husby G; Messner RP
    J Lab Clin Med; 1977 Feb; 89(2):240-9. PubMed ID: 319179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of antilymphocyte antibody with two-color method in systemic lupus erythematosus and its heterogeneous specificities against human T-cell subsets.
    Okudaira K; Nakai H; Hayakawa T; Kashiwado T; Tanimoto K; Horiuchi Y; Juji T
    J Clin Invest; 1979 Nov; 64(5):1213-20. PubMed ID: 91623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T lymphocyte subsets in systemic lupus erythematosus. Correlations with corticosteroid therapy and disease activity.
    Bakke AC; Kirkland PA; Kitridou RC; Quismorio FP; Rea T; Ehresmann GR; Horwitz DA
    Arthritis Rheum; 1983 Jun; 26(6):745-50. PubMed ID: 6602614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners.
    Ozturk GE; Kohler PF; Horsburgh CR; Kirkpatrick CH
    J Clin Immunol; 1987 Mar; 7(2):130-9. PubMed ID: 3033011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations.
    Reinherz EL; Morimoto C; Fitzgerald KA; Hussey RE; Daley JF; Schlossman SF
    J Immunol; 1982 Jan; 128(1):463-8. PubMed ID: 6459376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of anti-T cell autoantibodies from systemic lupus erythematosus sera upon T lymphocyte functions.
    Goldschmidt LP; Kresina TF; Kammer GM
    Arthritis Rheum; 1986 May; 29(5):646-54. PubMed ID: 3487322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphocytotoxic antibodies in systemic lupus erythematosus and clinically related diseases.
    Schocket AL; Kohler PF
    Arthritis Rheum; 1979 Oct; 22(10):1060-3. PubMed ID: 39565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.